The CHA2DS2VASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation

Journal of Cardiology

Volumn 65, Issue 2, 2015, Pages 121-127

  Kim, Kyung Hwan ^a   Kim, Wan ^a   Hwang, Sun Ho ^a   Kang, Won Yu ^a   Cho, Sang Cheol ^a   Kim, Weon ^b   Jeong, Myung Ho ^c  

^a Gwangju Veterans Hospital   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Acute myocardial infarction; CHA2DS2VASc score; Major adverse cardiac event

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHA2DS2VASC SCORE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; EVENT FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CLASSIFICATION; COMPLICATION; DISEASE FREE SURVIVAL; EVALUATION STUDY; HEALTH STATUS INDICATOR; HEART INFARCTION; INCIDENCE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; RECURRENT DISEASE; RISK FACTOR; SOUTH KOREA; TIME;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; RECURRENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84922803589     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.04.011     Document Type: Article

References (23)

1. Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000, 102:2031-2037.
2. Granger C.B., Goldberg R.J., Dabbous O., Pieper K.S., Eagle K.A., Cannon C.P., Van De Werf F., Avezum A., Goodman S.G., Flather M.D., Fox K.A. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353. Global Registry of Acute Coronary Events Investigators.
3. Eagle K.A., Lim M.J., Dabbous O.H., Pieper K.S., Goldberg R.J., Van de Werf F., Goodman S.G., Granger C.B., Steg P.G., Gore J.M., Budaj A., Avezum A., Flather M.D., Fox K.A. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month post-discharge death in an international registry. J Am Med Assoc 2004, 291:2727-2733. GRACE Investigators.
4. Poçi D., Hartford M., Karlsson T., Herlitz J., Edvardsson N., Caidahl K. Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation. Chest 2012, 141:1431-1440.
5. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.A., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010, 137:263-272.
6. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus H.A., Lindahl B., Morrow D.A., Clemmensen P.M., Johanson P., Hod H., Underwood R., Bax J.J., et al. Third universal definition of myocardial infarction. Circulation 2012, 126:2020-2035.
7. Pizzetti F., Turazza F.M., Franzosi M.G., Barlera S., Ledda A., Maggioni A.P., Santoro L., Tognoni G. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 2001, 86:527-532. GISSI-3 Investigators.
8. Avezum A., Makdisse M., Spencer F., Gore J.M., Fox K.A., Montalescot G., Eagle K.A., White K., Mehta R.H., Knobel E., Collet J.P. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005, 149:67-73. GRACE Investigators.
9. Gustafsson F., Køber L., Torp-Pedersen C., Hildebrandt P., Ottesen M.M., Sonne B., Carlsen J. Long-term prognosis after acute myocardial infarction in patients with a history of arterial hypertension. TRACE study group. Eur Heart J 1998, 19:588-594.
10. Malmberg K., Yusuf S., Gerstein H.C., Brown J., Zhao F., Hunt D., Piegas L., Calvin J., Keltai M., Budaj A. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000, 102:1014-1019.
11. Reynolds H.R., Forman S.A., Tamis-Holland J.E., Steg P.G., Mark D.B., Pearte C.A., Carvalho A.C., Sopko G., Liu L., Lamas G.A., Kruk M., Loboz-Grudzien K., Ruzyllo W., Hochman J.S. Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT). Am Heart J 2012, 163:462-469.
12. Omland T., Aakvaag A., Bonarjee V.V., Caidahl K., Lie R.T., Nilsen D.W., Sundsfjord J.A., Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996, 93:1963-1969.
13. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., Buttimore R.C., Lainchbury J.G., Elliott J.M., Ikram H., Crozier I.G., Smyth D.W. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998, 97:1921-1929.
14. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., Hartford M., Caidahl K. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002, 106:2913-2918.
15. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003, 107:2786-2792.
16. Tapanainen J.M., Lindgren K.S., Mäkikallio T.H., Vuolteenaho O., Leppäluoto J., Huikuri H.V. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004, 43:757-763.
17. Mega J.L., Morrow D.A., De Lemos J.A., Sabatine M.S., Murphy S.A., Rifai N., Gibson C.M., Antman E.M., Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004, 44:335-339.
18. Khan S.Q., Quinn P., Davies J.E., Ng L.L. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Heart 2008, 94:40-43.
19. Ang D.S., Wei L., Kao M.P., Lang C.C., Struthers A.D. A comparison between B-type natriuretic peptide, Global Registry of Acute Coronary Events (GRACE) score and their combination in ACS risk stratification. Heart 2009, 95:1836-1842.
20. Suleiman M., Aronson D., Reisner S.A., Kapeliovich M.R., Markiewicz W., Levy Y., Hammerman H. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003, 115:695-701.
21. Suleiman M., Khatib R., Agmon Y., Mahamid R., Boulos M., Kapeliovich M., Levy Y., Beyar R., Markiewicz W., Hammerman H., Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006, 47:962-968.
22. De Luca G., Suryapranata H., van't Hof A.W., de Boer M.J., Hoorntje J.C., Dambrink J.H., Gosselink A.T., Ottervanger J.P., Zijlstra F. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 2004, 109:2737-2743.
23. Halkin A., Singh M., Nikolsky E., Grines C.L., Tcheng J.E., Garcia E., Cox D.A., Turco M., Stuckey T.D., Na Y., Lansky A.J., Gersh B.J., O'Neill W.W., Mehran R., Stone G.W. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005, 45:1397-1405.